# GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration

> **NCT03739268** · NA · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 17 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sevelamer
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03739268
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-09-03
- **Final completion:** 2021-09-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739268, "GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03739268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*